2009 related articles for article (PubMed ID: 30231877)
1. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
2. Recent Insights into Effective Nanomaterials and Biomacromolecules Conjugation in Advanced Drug Targeting.
Azandaryani AH; Kashanian S; Jamshidnejad-Tosaramandani T
Curr Pharm Biotechnol; 2019; 20(7):526-541. PubMed ID: 31038063
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
[TBL] [Abstract][Full Text] [Related]
5. Nano-based drug delivery system for therapeutics: a comprehensive review.
Prakash S
Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
7. Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.
Kumar A; Chen F; Mozhi A; Zhang X; Zhao Y; Xue X; Hao Y; Zhang X; Wang PC; Liang XJ
Nanoscale; 2013 Sep; 5(18):8307-8325. PubMed ID: 23860639
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional DNA Origami Nanoplatforms for Drug Delivery.
Lu X; Liu J; Wu X; Ding B
Chem Asian J; 2019 Jul; 14(13):2193-2202. PubMed ID: 31125182
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
[TBL] [Abstract][Full Text] [Related]
10. Prospectives and challenges of nano-tailored biomaterials-assisted biological molecules delivery for tissue engineering purposes.
El-Nablaway M; Rashed F; Taher ES; Foda T; Abdeen A; Abdo M; Fericean L; Ioan BD; Mihaela O; Dinu S; Alexandru CC; Taymour N; Mohammed NA; El-Sherbiny M; Ibrahim AM; Zaghamir DE; Atia GA
Life Sci; 2024 Jul; 349():122671. PubMed ID: 38697279
[TBL] [Abstract][Full Text] [Related]
11. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
12. Nanostructure-mediated drug delivery.
Hughes GA
Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
[TBL] [Abstract][Full Text] [Related]
13. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
Hua S; Marks E; Schneider JJ; Keely S
Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial nanomedicine.
Yacoby I; Benhar I
Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
17. Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities.
Carrion CC; Nasrollahzadeh M; Sajjadi M; Jaleh B; Soufi GJ; Iravani S
Int J Biol Macromol; 2021 May; 178():193-228. PubMed ID: 33631269
[TBL] [Abstract][Full Text] [Related]
18. NanoDDS 2017: The 15th International Nanomedicine & Drug Delivery Symposium.
Moon JJ; Hennink WE; Schwendeman SP; Schwendeman A
J Control Release; 2018 Jul; 282():1-2. PubMed ID: 29914688
[No Abstract] [Full Text] [Related]
19. Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.
Yang H
Nanomedicine; 2016 Feb; 12(2):309-16. PubMed ID: 26706410
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers as Administration Systems of Natural Products.
Solís-Cruz GY; Pérez-López LA; Alvarez-Roman R; Rivas-Galindo VM; Silva-Mares DA; Ibarra-Rivera TR
Curr Top Med Chem; 2021; 21(26):2365-2373. PubMed ID: 34525921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
